MMP9 and inflammatory bowel disease: The alteration of ECM in IBD is characterized by inflammatory mediators and activated matrix metalloproteinase‐9 (MMP9), which increases intestinal permeability, epithelial apoptosis and loss of goblet cells in colitis in humans.51